- COPD is a chronic inflammatory lung disease causing tissue destruction and irreversible airflow limitation

- Smoking is the most common risk factor worldwide

- Patients should be screened for AATD

- COPD most commonly affects adults >40 years old

- Diagnosis is made by spirometry with a post-bronchodilator FEV1/FVC ratio < 0.7

- Patients should avoid smoking and other harmful exposures

- Annual influenza vaccination is recommended for all patients with COPD

- PCV13 and PPSV23 at least 1 year apart is recommended for patients aged 65 or greater

- PPSV23 is recommended in COPD patients under age 65 with significant comorbid conditions

- Pharmacologic treatment typically involves the use of bronchodilators and inhaled corticosteroids

- Complications commonly include acute exacerbations, pulmonary hypertension, and bacterial pneumonia

- Patients with a smoking history who meet screening criteria should be monitored for lung cancer

- Criteria for lung cancer screening with low-dose computed tomography 
- Age 55-80
- 30+ pack-year smoking history
- Current smoker or quit within the past 15 years

- Lung transplantation may improve functional capacity but not prolong survival